HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sweden Reverse-Switches Diclofenac Over Cardio Fears

Executive Summary

Oral diclofenac will no longer be available without a prescription in Sweden after the national drug regulator judged that the potential adverse event risks were too high to justify continued OTC supply. Products from GSK and Mylan will be affected by the decision.

You may also be interested in...



Bayer Hit With Fine For Ads Targeting Kids In Hungary

Bayer broke rules on advertising directly to children in promotions for its Supradyn supplement, according to Hungary's competition authority, which imposed a fine on the company for the second time in 12 months. 

GSK Launches OTC Fluticasone In Japan Following Switch

GSK has launched Flunase in Japan following the switch of fluticasone propionate. JSMI’s Toshi Tominaga gives his assessment of the product’s prospects as an OTC drug.

Stada’s Acquisition Spree Continues With Deal For Ukrainian Probiotics Player

Germany's Stada will gain a range of probiotics and other OTC brands through the acquisition of Ukraine's Biopharma. The deal is Stada's third in the space of just one month. 

Topics

Related Companies

UsernamePublicRestriction

Register

RS149413

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel